AI assistant
Sending…
ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2021
Aug 4, 2021
32464_dirs_2021-08-04_e7a5f9f4-6583-4196-8d08-bdeaf519ca1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2021-08-02
Reporting Person: MISSLING CHRISTOPHER U (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-02 | Stock Option (Right to Buy) | $18.11 | A | 500000 | Acquired | 2031-08-02 | Common Stock (500000) | Direct |
Footnotes
F1: The options shall vest upon achieving a key enrollment milestone in a late stage clinical study.
More from ANAVEX LIFE SCIENCES CORP.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Feb 25
Interim / Quarterly Report
2026
Feb 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Annual Report
2025
Nov 25
Regulatory Filings
2025
Nov 25